(Press-News.org) MEXICO CITY, MEXICO, 29 July 2025 -- In a revealing Genomic Press Interview published today in Brain Medicine, Dr. Camilo de la Fuente-Sandoval shares how personal history and scientific passion converged to create groundbreaking advances in schizophrenia treatment prediction. The distinguished neuroscientist, recently honored with the Schizophrenia International Research Society's prestigious 2024 Global Schizophrenia Award, has established a unique research paradigm that combines cutting-edge neuroimaging with comprehensive clinical care in one of Latin America's most populous urban centers.
From Political Exile to Scientific Excellence
The journey that led Dr. de la Fuente-Sandoval to become a leading voice in psychosis research began with displacement. His father, a researcher forced to flee Chile for political reasons, saw his scientific career abruptly terminated. This family history of interrupted scientific pursuit became a driving force that would later shape the younger de la Fuente-Sandoval's determination to build something lasting in neuroscience research.
During his psychiatry residency at the Instituto Nacional de Neurología y Neurocirugía, patients experiencing psychosis captivated his attention. Guided by fellow resident Ariel Graff-Guerrero, who had completed advanced neuroscience training, Dr. de la Fuente-Sandoval embarked on spectroscopy studies that would fundamentally alter understanding of early psychosis mechanisms. These initial investigations in both clinical high-risk subjects and first-episode psychosis patients revealed neurochemical alterations that had previously remained hidden from clinical observation.
The success of these early studies prompted institutional leadership to offer him laboratory space, catalyzing the creation of what would become the Laboratory of Experimental Psychiatry. This opportunity sparked an ambitious vision: developing imaging markers that could guide treatment selection rather than relying on the traditional trial-and-error approach that often delays effective intervention in young people experiencing their first psychotic episodes.
Revolutionary Care Model in Resource-Limited Settings
Operating within Mexico City's sprawling metropolitan area of 22 million residents, where mental health resources remain severely limited, Dr. de la Fuente-Sandoval has engineered an innovative clinical research ecosystem. His team established a specialized outpatient clinic staffed by laboratory-affiliated psychiatrists while simultaneously implementing comprehensive evaluation protocols in the emergency department.
This integrated approach ensures that first-episode psychosis patients receive immediate, thorough assessment including routine laboratory tests, head CT scans, and selective lumbar punctures based on clinical judgment. Remarkably, approximately 8% of patients presenting with first-episode psychosis are discovered to have secondary causes such as viral encephalitis or autoimmune conditions. Could this systematic screening approach, if implemented more broadly, prevent misdiagnosis and inappropriate treatment in similar patient populations worldwide?
All patients undergo comprehensive evaluation within 24 hours of emergency admission, including neuropsychological testing and MRI studies. This rapid assessment protocol serves dual purposes: enabling immediate treatment initiation while generating crucial research data. The entire process occurs at no cost to patients, addressing both scientific questions and healthcare access barriers simultaneously.
Glutamate: The Missing Piece in Treatment Prediction
The laboratory's most significant contribution centers on discoveries about glutamate dysfunction in early psychosis. Through sophisticated MRI spectroscopy techniques applied to antipsychotic-naïve patients, Dr. de la Fuente-Sandoval's team identified elevated glutamate levels specifically within the associative striatum. More importantly, they demonstrated that these elevations normalize following effective antipsychotic treatment.
This finding opens unprecedented possibilities for treatment personalization. Rather than subjecting patients to potentially ineffective medications for weeks or months, clinicians might soon predict treatment response through baseline neuroimaging assessments. What implications might this hold for reducing the duration of untreated psychosis, a factor strongly associated with long-term outcomes? The potential to match patients with optimal treatments from the outset represents a paradigm shift in psychiatric care delivery.
The research extends beyond glutamate to encompass electrophysiology, cognitive assessment, and inflammation markers. This multidimensional approach recognizes psychosis as a complex phenomenon requiring equally sophisticated investigative strategies. By integrating multiple biological markers, the laboratory works toward comprehensive predictive models that could transform clinical decision-making.
Building Global Collaborations from the Global South
Despite geographic and resource constraints, Dr. de la Fuente-Sandoval has positioned his laboratory at the forefront of international schizophrenia research. His leadership role in the ENIGMA Clinical High Risk for Psychosis Working Group facilitates data sharing and collaborative analyses across continents. This participation ensures that findings from Latin American populations contribute to global understanding of psychosis mechanisms.
The laboratory's success challenges assumptions about where cutting-edge neuroscience can flourish. By leveraging Mexico City's large patient population and combining it with rigorous scientific methodology, the team generates insights unavailable in better-resourced but smaller research settings. How might other investigators in resource-limited environments replicate this model of turning apparent disadvantages into scientific opportunities?
Dr. de la Fuente-Sandoval's Genomic Press interview is part of a larger series called Innovators & Ideas that highlights the people behind today's most influential scientific breakthroughs. Each interview in the series offers a blend of cutting-edge research and personal reflections, providing readers with a comprehensive view of the scientists shaping the future. By combining a focus on professional achievements with personal insights, this interview style invites a richer narrative that both engages and educates readers. This format provides an ideal starting point for profiles that explore the scientist's impact on the field, while also touching on broader human themes. More information on the research leaders and rising stars featured in our Innovators & Ideas -- Genomic Press Interview series can be found in our publications website: https://genomicpress.kglmeridian.com/.
The Genomic Press Interview in Brain Medicine titled "Camilo de la Fuente-Sandoval: Glutamate as biomarker of treatment response in early-stage schizophrenia," is freely available via Open Access on 29 July 2025 in Brain Medicine at the following hyperlink: https://doi.org/10.61373/bm025k.0092.
About Brain Medicine: Brain Medicine (ISSN: 2997-2639, online and 2997-2647, print) is a peer-reviewed medical research journal published by Genomic Press, New York. Brain Medicine is a new home for the cross-disciplinary pathway from innovation in fundamental neuroscience to translational initiatives in brain medicine. The journal's scope includes the underlying science, causes, outcomes, treatments, and societal impact of brain disorders, across all clinical disciplines and their interface.
Visit the Genomic Press Virtual Library: https://issues.genomicpress.com/bookcase/gtvov/
Our full website is at: https://genomicpress.kglmeridian.com/
END
Mexican neuroscientist identifies glutamate biomarker predicting schizophrenia treatment success
Dr. Camilo de la Fuente-Sandoval transforms early psychosis care through neuroimaging breakthroughs
2025-07-29
ELSE PRESS RELEASES FROM THIS DATE:
Living brain tissue reveals 80% of genes behave differently than assumed
2025-07-29
NEW YORK, New York, USA, 29 July 2025 – In a revealing Genomic Press Interview published today in Genomic Psychiatry, Dr. Alexander W. Charney describes how treating patients with schizophrenia transformed his scientific pursuits from abstract questions to an urgent mission, ultimately leading to discoveries that challenge fundamental assumptions in neuroscience research.
The interview explores Dr. Charney's creation of the groundbreaking Living Brain Project at Mount Sinai, which has collected over 300 brain tissue samples from living patients undergoing neurosurgery. His team's findings reveal a startling reality: 80% of genes exhibit different expression levels in ...
How much time did our ancestors spend up trees? Studying these chimpanzees might help us find out
2025-07-29
It’s hard to tell when — and why — our ancestors got down from trees and started walking on two legs. Many early hominins capable of bipedal walking were also well-adapted for climbing, and we lack fossil evidence from a key period when climate change turned forests into open, dry woodland called savannah-mosaic, which might have pushed hominins onto the ground. Now a study on modern chimpanzees could help fill in the gaps. Scientists observing chimpanzees in the Issa Valley, Tanzania have shown that despite living in ...
Discovery of role of gut hormone in chronic diarrhoea could aid development of new tests and treatments
2025-07-29
High levels of a hormone found in cells in the gut could underlie many cases of chronic diarrhoea and help explain up to 40% of cases of patients with irritable bowel syndrome with diarrhoea, according to a new study led by scientists at the University of Cambridge.
The research, published in the journal Gut, could help in the development of a blood test and points towards a potential new treatment.
When we eat, the liver releases bile acid to break down fats so that they can be absorbed into the body. Bile acid is released into the top end of the small intestine and then absorbed back into the body at the lower ...
New discovery reveals the spinal cord’s role in bladder control
2025-07-29
Urinary incontinence is a devastating condition affecting over 33 million Americans, according to the National Association for Continence, leading to significant adverse impacts on patients’ mental health and quality of life. Disorders of urination are also a key feature of all neurological disorders.
A USC research team has now made major progress in understanding how the human spinal cord triggers the bladder emptying process. The discovery could lead to exciting new therapies to help patients regain control of ...
Kākāpō decline reveals threat of parasite coextinction
2025-07-29
Researchers from the University of Adelaide, New Zealand’s Manaaki Whenua-Landcare Research and University of Auckland have discovered that more than 80 per cent of parasites detected in kākāpō poo prior to the 1990s are no longer present in contemporary populations.
The project used ancient DNA and microscopic techniques to sample faeces dating back more than 1500 years, with nine of 16 original parasite taxa disappearing prior to the 1990s, when the endangered parrot came under full-population management, and an additional four recorded as lost in the period ...
Astrocytes identified as hidden culprit behind PTSD
2025-07-29
Did you know that patients with post traumatic stress disorder (PTSD) often struggle to forget traumatic memories, even long after the danger has passed? This failure to extinguish fear memories has long puzzled scientists and posed a major hurdle for treatment, especially since current medications targeting serotonin receptors offer limited relief for only a subset of patients.
In a new discovery, scientists at the Institute for Basic Science (IBS) and Ewha Womans University have uncovered a new brain mechanism driving PTSD — and a promising drug that may counteract its effects.
Led by Dr. C. Justin ...
Offering self-collection kits in routine GP appointments could prevent 1,000 women a year from developing cervical cancer
2025-07-29
UNDER STRICT EMBARGO UNTIL 11.30 PM (UTC) ON MONDAY 28 JULY 2025
Peer reviewed | Randomised Controlled Trial | People
Offering self-collection kits in routine GP appointments could prevent 1,000 women a year from developing cervical cancer
Women who are overdue for cervical cancer screening are most likely to participate in screening when a self-sampling kit is offered by a healthcare professional as part of routine GP appointments, according to a new study led by Queen Mary University of London with King’s College London. Over half of ...
European study offers clearer picture of childhood brain tumor survival
2025-07-28
European study offers clearer picture of childhood brain tumor survival
Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren’t recorded in the same way everywhere in Europe. A new study led by the Princess Máxima Center is helping to change that. For the first time, the research provides a clear and clinically relevant overview of survival outcomes for children with brain tumors.
Researchers at the Princess Máxima ...
The Lancet: Three in five liver cancer cases due to preventable risk factors; obesity-linked cases on the rise, new analysis suggest
2025-07-28
**Embargo: 23.30 [UK time] / 6.30pm [US ET] Monday 28th July 2025**
Peer-reviewed / Modelling study, Review and Opinion / People
Embargoed access to the Commission report and contact details for authors are available in Notes to Editors at the end of the release.
The Lancet: Three in five liver cancer cases due to preventable risk factors; obesity-linked cases on the rise, new analysis suggest
Over 60% of liver cancers globally are preventable through reduction of risk factors including viral hepatitis, alcohol and metabolic dysfunction-associated steatotic liver disease (MASLD) - a long-term liver condition caused ...
Tiny artificial cells can keep time, study finds
2025-07-28
A team of UC Merced researchers has shown that tiny artificial cells can accurately keep time, mimicking the daily rhythms found in living organisms. Their findings shed light on how biological clocks stay on schedule despite the inherent molecular noise inside cells.
The study, recently published in Nature Communications, was led by bioengineering Professor Anand Bala Subramaniam and chemistry and biochemistry Professor Andy LiWang. The first author, Alexander Zhang Tu Li, earned his Ph.D. in Subramaniam’s lab.
Biological clocks — also known as circadian rhythms — govern 24-hour cycles that regulate sleep, metabolism and other vital processes. ...
LAST 30 PRESS RELEASES:
miRNA dysregulation of AGE/RAGE pathway in metabolic syndrome: a novel analysis strategy utilizing miRNA-profiling data
AI catches one-third of interval breast cancers missed at screening
Researchers advocate for separate roles between AI and humans
SwRI expands antenna testing capabilities with spherical near-field range
The complex relationship between fusion fuel and lithium walls
Study refutes blood thinner brain bleed risk after falls in older adults
"Breakthrough in progeria therapy: RNA scissors precisely target and remove mutant gene"
The Mount Sinai Hospital ranked among top in the nation by US News & World Report®
Storage process: a new method reduces the acute toxicity of the essential oil of Artemisia argyi H. Lév. & Vaniot by 40%
Licensed to live
How to survive the explosion of AI slop
GDF-15 and eGFRdiff: Predicting kidney risk and survival in diabetes mellitus
Detecting cancer cells in blood: the development of microchannel devices with microcone arrays
SLAS Discovery: Advancing tools for cancer fibrosis and drug discovery
Researchers create ‘virtual scientists’ to solve complex biological problems
AI-Powered brain stimulation at home could enhance concentration, new research finds
Carbon-based molecules open new pathways for quantum sensing
Immunotherapy for leukemia may affect the bone marrow environment, cancer researchers find
World’s largest tropical peatlands revealed to be more than 40,000 years old
Pick up the pace of your daily walk to boost longevity, experts say
Normal hormone levels trigger severe depression in some women; researcher discovers mechanism
Mexican neuroscientist identifies glutamate biomarker predicting schizophrenia treatment success
Living brain tissue reveals 80% of genes behave differently than assumed
How much time did our ancestors spend up trees? Studying these chimpanzees might help us find out
Discovery of role of gut hormone in chronic diarrhoea could aid development of new tests and treatments
New discovery reveals the spinal cord’s role in bladder control
Kākāpō decline reveals threat of parasite coextinction
Astrocytes identified as hidden culprit behind PTSD
Offering self-collection kits in routine GP appointments could prevent 1,000 women a year from developing cervical cancer
European study offers clearer picture of childhood brain tumor survival
[Press-News.org] Mexican neuroscientist identifies glutamate biomarker predicting schizophrenia treatment successDr. Camilo de la Fuente-Sandoval transforms early psychosis care through neuroimaging breakthroughs